These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6883395)

  • 1. Tumor markers derived from nucleic acid components.
    Borek E; Waalkes TP; Gehrke CW
    Cancer Detect Prev; 1983; 6(1-2):67-71. PubMed ID: 6883395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
    Fischbein A; Sharma OK; Selikoff IJ; Borek E
    Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High turnover rate of transfer RNA in tumor tissue.
    Borek E; Baliga BS; Gehrke CW; Kuo CW; Belman S; Troll W; Waalkes TP
    Cancer Res; 1977 Sep; 37(9):3362-6. PubMed ID: 884680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on nucleic acid metabolism. Molecular biology and clinical significance].
    Schöch G
    Fortschr Med; 1978 Oct; 96(37):1875-80. PubMed ID: 700570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of urinary excretion of modified nucleosides.
    Gehrke CW; Kuo KC; Waalkes TP; Borek E
    Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified nucleosides in body fluids of tumor-bearing patients.
    Salvatore F; Colonna A; Costanzo F; Russo T; Esposito F; Cimino F
    Recent Results Cancer Res; 1983; 84():360-77. PubMed ID: 6844698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new family of tumor markers.
    Borek E
    Cancer Detect Prev; 1981; 4(1-4):185-91. PubMed ID: 7349776
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
    Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
    Xu G; Schmid HR; Lu X; Liebich HM; Lu P
    Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modified nucleosides in tRNA: its structure, biosynthesis and function (author's transl)].
    Nishimura S
    Tanpakushitsu Kakusan Koso; 1977 Jun; 22 Spec No(7):922-30. PubMed ID: 329357
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
    Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
    Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD; Patel MI; Sheinfeld J
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
    Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
    Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative enzymatic hydrolysis of tRNAs: reversed-phase high-performance liquid chromatography of tRNA nucleosides.
    Gehrke CW; Kuo KC; McCune RA; Gerhardt KO; Agris PF
    J Chromatogr; 1982 Jul; 230(2):297-308. PubMed ID: 7050138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Codon recognition by artificial tRNA molecules with modified nucleosides in the anticodon.
    Satoh A; Takai K; Yokoyama S; Takaku H
    Nucleic Acids Symp Ser; 1997; (37):117-8. PubMed ID: 9586027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
    Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
    Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
    Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
    Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of RNA containing O-beta-D-ribofuranosyl-(1''-2')-adenosine-5''-phosphate and 1-methyladenosine, minor components of tRNA.
    Mikhailov SN; Efimtseva EV; Rodionov AA; Shelkunova AA; Rozenski J; Emmerechts G; Schepers G; Van Aerschot A; Herdewijn P
    Chem Biodivers; 2005 Sep; 2(9):1153-63. PubMed ID: 17193197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE.
    Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H
    Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.